{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:33:07Z","timestamp":1793075587657,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032442","name":"Gene Solutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofliquidbiopsy.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Liquid Biopsy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jlb.2026.100496","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:49:59Z","timestamp":1789832999000},"page":"100496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A streamlined hybrid-capture and genome-wide multi-omic platform for highly sensitive ctDNA minimal residual disease monitoring"],"prefix":"10.1016","volume":"14","author":[{"given":"Tu","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van-Anh","family":"Nguyen Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cang","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Son-Nam H.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quang Thinh","family":"Trac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thien-Phuc","family":"Nguyen Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhat-Anh","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh Tran Binh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam HB.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duy Minh","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoa","family":"Giang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoai-Nghia","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6362-8554","authenticated-orcid":false,"given":"Lan N.","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jlb.2026.100496_bib1","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1158\/2159-8290.CD-21-0634","article-title":"Detecting liquid remnants of solid tumors: circulating tumor DNA minimal residual disease","volume":"11","author":"Moding","year":"2021","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.jlb.2026.100496_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40291-021-00559-x","article-title":"Commercial ctDNA assays for minimal residual disease detection of solid tumors","volume":"25","author":"Chen","year":"2021","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.jlb.2026.100496_bib3","first-page":"142","article-title":"Clinical performance of tumor-informed versus tumor-agnostic ctDNA assays for colorectal cancer recurrence: a systematic review and diagnostic accuracy meta-analysis","author":"Camblor","year":"2026","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jlb.2026.100496_bib4","article-title":"Clinical trial and real-world evidence of circulating tumor DNA monitoring to predict recurrence in patients with resected colorectal cancer","volume":"6","author":"Nguyen","year":"2024","journal-title":"ESMO Real World Data Digital Oncol"},{"key":"10.1016\/j.jlb.2026.100496_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1069296","article-title":"Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patients","volume":"12","author":"Nguyen","year":"2022","journal-title":"Frontiers in oncology"},{"issue":"2","key":"10.1016\/j.jlb.2026.100496_bib6","doi-asserted-by":"crossref","DOI":"10.1200\/OA-24-00084","article-title":"Real-world utilization and performance of circulating tumor DNA monitoring to predict recurrence in solid tumors","author":"Nguyen Hoang","year":"2025","journal-title":"JCO Oncol Adv"},{"key":"10.1016\/j.jlb.2026.100496_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/17588359251393090","article-title":"Tumor-naive multimodal profiling of circulating tumor DNA to detect minimal residual disease in solid tumors","volume":"17","author":"Nguyen","year":"2025","journal-title":"Ther Adv Med Oncol"},{"issue":"4","key":"10.1016\/j.jlb.2026.100496_bib8","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1878-0261.13356","article-title":"Genetic landscape and personalized tracking of tumor mutations in Vietnamese women with breast cancer","volume":"17","author":"Nguyen Hoang","year":"2023","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.jlb.2026.100496_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41523-025-00778-z","article-title":"Personalized mutation tracking in circulating-tumor DNA predicts recurrence in patients with high-risk early breast cancer","volume":"11","author":"Nguyen","year":"2025","journal-title":"npj Breast Cancer"},{"issue":"1","key":"10.1016\/j.jlb.2026.100496_bib10","article-title":"Direct comparison of tumor-informed and tumor-naive circulating tumor DNA assays for recurrence detection in early-stage NSCLC","volume":"7","author":"Nguyen Hoang","year":"2026","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.jlb.2026.100496_bib11","unstructured":"Fulcrum G: Fgbio: tools for working with genomic and high throughput sequencing data."},{"key":"10.1016\/j.jlb.2026.100496_bib12","unstructured":"Broad I: Picprd Toolkit."},{"issue":"6","key":"10.1016\/j.jlb.2026.100496_bib13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1101\/gr.229102","article-title":"The human genome browser at UCSC","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res"},{"issue":"3","key":"10.1016\/j.jlb.2026.100496_bib14","first-page":"511","article-title":"FATHMM-XF: accurate prediction of pathogenic point mutations via extended features","volume":"34","author":"Rogers","year":"2018","journal-title":"Bioinformatics (Oxford, England)"},{"key":"10.1016\/j.jlb.2026.100496_bib15","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.89083.3","article-title":"Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization","volume":"12","author":"Nguyen","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.jlb.2026.100496_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1332004","article-title":"A review on the impact of single-stranded library preparation on plasma cell-free diversity for cancer detection","volume":"14","author":"Cheng","year":"2024","journal-title":"Frontiers in oncology"},{"issue":"9","key":"10.1016\/j.jlb.2026.100496_bib17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/s41587-021-00857-z","article-title":"Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology","volume":"39","author":"Deveson","year":"2021","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.jlb.2026.100496_bib18","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1186\/s12967-025-06993-3","article-title":"GeneBits: ultra-sensitive tumour-informed ctDNA monitoring of treatment response and relapse in cancer patients","volume":"23","author":"Broche","year":"2025","journal-title":"J Transl Med"},{"issue":"10","key":"10.1016\/j.jlb.2026.100496_bib19","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.ccell.2023.08.010","article-title":"Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer","volume":"41","author":"Chen","year":"2023","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.jlb.2026.100496_bib20","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41591-020-0915-3","article-title":"Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring","volume":"26","author":"Zviran","year":"2020","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.jlb.2026.100496_bib21","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1158\/1078-0432.CCR-19-3005","article-title":"Sensitive detection of minimal residual disease in patients treated for early-stage breast cancer","volume":"26","author":"Parsons","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"19","key":"10.1016\/j.jlb.2026.100496_bib22","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1158\/1078-0432.CCR-24-1651","article-title":"Colorectal cancer recurrence prediction using a tissue-free epigenomic minimal residual disease assay","volume":"30","author":"Nakamura","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"9_Supplement","key":"10.1016\/j.jlb.2026.100496_bib23","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS23-PS06-06","article-title":"Abstract PS06-06: analysis of ctDNA for the detection of minimal residual disease (MRD) using a tissue-free, multiomic assay in patients with early-stage breast cancer","volume":"84","author":"Janni","year":"2024","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.jlb.2026.100496_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.104296","article-title":"Detection of minimal residual disease and prediction of recurrence in breast cancer using a plasma-only circulating tumor DNA assay","volume":"10","author":"Janni","year":"2025","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.jlb.2026.100496_bib25","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1038\/s41467-024-53017-7","article-title":"Cancer treatment monitoring using cell-free DNA fragmentomes","volume":"15","author":"van 't Erve","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.jlb.2026.100496_bib26","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41591-024-03040-4","article-title":"Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment","volume":"30","author":"Widman","year":"2024","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jlb.2026.100496_bib27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1878-0261.13105","article-title":"Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study","volume":"16","author":"Zhu","year":"2022","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jlb.2026.100496_bib28","article-title":"Prognostic value of postoperative circulating tumor DNA in patients with Early- and intermediate-stage hepatocellular carcinoma","volume":"12","author":"Ye","year":"2022","journal-title":"Frontiers in oncology"},{"issue":"4","key":"10.1016\/j.jlb.2026.100496_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.793","article-title":"Integrated analysis of circulating tumour cells and circulating tumour DNA to detect minimal residual disease in hepatocellular carcinoma","volume":"12","author":"Zhao","year":"2022","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jlb.2026.100496_bib30","article-title":"Feasibility of personalized and tumor-informed circulating tumor DNA assay for early recurrence detection in patients with hepatocellular carcinoma","volume":"9","author":"Abdelrahim","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jlb.2026.100496_bib31","article-title":"Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection","volume":"13","author":"Xu","year":"2023","journal-title":"Frontiers in oncology"}],"container-title":["The Journal of Liquid Biopsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950195426000421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950195426000421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:00:04Z","timestamp":1793073604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950195426000421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":31,"alternative-id":["S2950195426000421"],"URL":"https:\/\/doi.org\/10.1016\/j.jlb.2026.100496","relation":{},"ISSN":["2950-1954"],"issn-type":[{"value":"2950-1954","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A streamlined hybrid-capture and genome-wide multi-omic platform for highly sensitive ctDNA minimal residual disease monitoring","name":"articletitle","label":"Article Title"},{"value":"The Journal of Liquid Biopsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlb.2026.100496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of The International Society of Liquid Biopsy.","name":"copyright","label":"Copyright"}],"article-number":"100496"}}